ILLUMNIS Trademark

Trademark Overview

On Thursday, November 1, 2018, a trademark application was filed for ILLUMNIS with the United States Patent and Trademark Office. The USPTO has given the ILLUMNIS trademark a serial number of 79247064. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Tuesday, March 17, 2020. This trademark is owned by Bioeq IP AG. The ILLUMNIS trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the treatment of age-related macular degeneration
illumnis

General Information

Serial Number79247064
Word MarkILLUMNIS
Filing DateThursday, November 1, 2018
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateTuesday, March 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2019

Trademark Statements

Goods and ServicesMedicines for the treatment of age-related macular degeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, March 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioeq AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameBioeq IP AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Monday, April 12, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 17, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 17, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 6, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 6, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, May 2, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, May 1, 2020DEATH OF INTERNATIONAL REGISTRATION
Tuesday, March 17, 2020ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Tuesday, March 17, 2020ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, March 17, 2020OPPOSITION TERMINATED NO. 999999
Tuesday, March 17, 2020OPPOSITION SUSTAINED NO. 999999
Tuesday, March 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, August 9, 2019REFUSAL PROCESSED BY IB
Thursday, July 25, 2019OPPOSITION INSTITUTED NO. 999999
Tuesday, July 23, 2019OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Tuesday, July 23, 2019OPPOSITION NOTICE (IB REFUSAL) CREATED
Tuesday, March 26, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 6, 2019NOTICE OF PUBLICATION
Wednesday, February 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 7, 2019ASSIGNED TO EXAMINER
Tuesday, December 18, 2018APPLICATION FILING RECEIPT MAILED
Thursday, December 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 6, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

illumnis degeneration macular related treatment medicines